Aptar and Propeller Health partner on digital medicines platform

Drug delivery system provider Aptar Pharma has collaborated with local digital therapeutics firm Propeller Health to introduce a comprehensive platform for the development of digital medicines across various therapeutic areas and diseases.

The platform will integrate software with connected drug delivery device expertise in order to improve treatment effectiveness and clinical outcomes for patients.

The platform will cover inhaled, injectable, nasal and dermal medicine delivery.

Under the alliance, Aptar will combine its device development, manufacturing and packaging experience with Propeller’s platform as well as design and implementation expertise for digital therapeutics.

The partners intend to collaborate with other pharmaceutical and healthcare organisations to better develop, manufacture and commercialise digital medicines for certain marketed and pipeline brands.

Aptar Pharma president Salim Haffar said: "Aptar Pharma has been providing innovative drug delivery systems for nearly 50 years, helping billions of patients around the world.

"We are excited to broaden our offerings as we continue this journey towards improved patient care and clinical outcomes by growing our partnership with Propeller Health."

"Today, we are excited to broaden our offerings as we continue this journey towards improved patient care and clinical outcomes by growing our partnership with Propeller Health, the leader in their field of digital therapeutics."

Register as Visitor to CPhI China 2018!